Blood Biomarker for Frontotemporal Dementia Affirmed - Technology Networks

Researchers at the Mayo clinic have reported that neurofilament light is a biomarker for frontotemporal dementia, potentially allowing for quicker diagnoses.

A test of protein in the blood gets further support as a biomarker for patients diagnosed with frontotemporal dementia (FTD), a group of brain disorders with few treatment options. These disorders ar… [+3844 chars]

full article...